Bosh sahifaLSTA • NASDAQ
add
Lisata Therapeutics Inc
Yopilish kursi
5,02 $
Kunlik diapazon
5,01 $ - 5,04 $
Yillik diapazon
1,81 $ - 5,06 $
Bozor kapitalizatsiyasi
44,37 mln USD
Oʻrtacha hajm
91,16 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Bozor yangiliklari
CNBC
22 soat oldin
Bitcoin beat the S&P 500, Nasdaq Composite and gold since the start of the Iran war
0,15%
0,61%
1,75%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 100,00 ming | -90,00% |
Joriy xarajat | 3,18 mln | -46,56% |
Sof foyda | -2,95 mln | 35,92% |
Sof foyda marjasi | -2,95 ming | -540,78% |
Har bir ulushga tushum | — | — |
EBITDA | -3,06 mln | 37,57% |
Amaldagi soliq stavkasi | 0,00% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 15,96 mln | -48,93% |
Jami aktivlari | 17,74 mln | -49,31% |
Jami passivlari | 3,14 mln | -44,71% |
Umumiy kapital | 14,60 mln | — |
Tarqatilgan aksiyalar | 9,03 mln | — |
Narxi/balansdagi bahosi | 2,99 | — |
Aktivlardan daromad | -38,97% | — |
Kapitaldan daromad | -48,53% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -2,95 mln | 35,92% |
Operatsiyalardan naqd pul | -3,25 mln | 28,25% |
Sarmoyadan naqd pul | 0,00 | -100,00% |
Moliyadan naqd pul | 205,00 ming | 313,54% |
Naqd pulning sof oʻzgarishi | -3,04 mln | 7,82% |
Boʻsh pul | -3,58 mln | -21,34% |
Haqida
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
In 2019, the FDA granted their product, certepetide, orphan drug status in pancreatic cancer, followed by a Fast track status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia
Tashkil etilgan
1980
Sayt
Xodimlar soni
26
